Gene Query: KDELR1

Dataset Description Geneva Score
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 38.13
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 37.88
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 37.13
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 34.5
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 28.26
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 28.17
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 27.27
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 25.88
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 23.36
Transcriptomic analyssis following EHMT1/2 inhibition 22.36
Triple vectors expand AAV transfer capacity in the retina 22.27
IDH3a KO RNA-seq 22.12
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 21.72
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 21.28
Knockdown of ADNP in HCT116 colon cancer cells 20.08
Impact of dieldrin on transcription in Jurkat T cells 19.93
The interplay between SOX4 and SMAD3 in the context of breast cancer 19.41
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 19.31
Transcriptome analysis of kidney organoids 19.21
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 19.11
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 18.41
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 17.96
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 17.96
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 17.77
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 16.99
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 16.99
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 16.89
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 16.81
Expression profiling of MCF-7 cells with treatment of TCDD 16.81
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 16.43
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 16.37
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 16.37
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 15.92
Microprocessor mediates transcription termination in long noncoding microRNA genes 15.79
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 15.74
Differentiation enhances Zika virus infection in neuronal brain cells 15.59
Pharmacologic inhibition of STAT5 in AML 14.7
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 14.58
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 14.44
circRNA-sequencing 14.39
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 14.05
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 13.88
Aortic Valve Tissue: Stenosis vs. Sclerosis 13.72
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 13.7
Solid phase chemistry to covalently and reversibly capture thiolated RNA 13.65
Expression profiling of etoposide-induced senescent cells 13.5
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 13.4
SLIGRL-induced gene expression changes in NHEK cells 13.12
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.93
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 12.58
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 12.52
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 12.35
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 12.32
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 12.27
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 12.24
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 12.24
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 12.23
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 12.23
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 12.23
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 12.23
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 12.16
High-throughput sequencing of pluripotent cells 12.07
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 12.0
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.73
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 11.72
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 11.67
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 11.65
Global transcriptome analysis of HAP1 cells 11.47
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 11.24
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 11.24
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 11.2
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 11.11
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.83
Effect of from Human Umbilical Vein Endothelial Cells 10.82
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 10.79
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 10.77
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 10.77
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 10.73
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 10.73
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.65
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 10.54
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 10.54
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 10.49
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 10.34
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 10.21
Ebola virus (EBOV) infection of ARPE-19 cells 10.12
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 10.06
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 9.94
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 9.86
Effect of FGF13 depletion on the H460 cell line 9.83
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 9.77
Mapping interactions for the TNIP2 hub protein 9.69
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 9.66
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 9.66
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 9.66
Uridylation by TUT4 and TUT7 marks mRNA for degradation 9.59
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 9.57
Landscape of H3K4me3 in human CD19 cells 9.46
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 9.4
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 9.4
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 9.39
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 9.38
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 9.38
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 9.3
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 9.24
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 9.12
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 9.12
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 9.1
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 9.1
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 9.1
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.08
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 9.06
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 9.02
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 8.99
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 8.99
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 8.94
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 8.94
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 8.94
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 8.89
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 8.89
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 8.84
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 8.83
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.76
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.71
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 8.7
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 8.7
Mitochondrial dsRNA triggers antiviral signalling in humans 8.7
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 8.67
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 8.66
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 8.66
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 8.63
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 8.54
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 8.54
Effect of PRDM11 depletion in U2932 cells 8.52
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 8.51
Transcriptome-wide identification of CELF2 functional targets in T cells 8.5
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 8.47
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 8.47
Molecular Mechanisms of Endothelial Hyperpermeability 8.4
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 8.38
RNA sequencing of BT142 and TS603 cell lines 8.38
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 8.36
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 8.35
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.29
RNA transcriptome analysis during HSV-1 infection 8.29
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.26
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 8.24
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 8.16
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 8.15
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 8.15
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.04
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 8.04
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 8.04
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 8.01
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 8.0
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 8.0
Role of XRN2 ribonucleolytic activity in RNA metabolism 7.99
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 7.94
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 7.78
RNA-sequencing of human liver tissue 7.77
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 7.76
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 7.75
DART-seq: an antibody-free method for global m6A detection 7.71
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 7.69
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 7.69
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 7.68
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 7.66
Global analysis of enhancer targets: Mosaic-seq 7.61
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.48
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 7.45
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 7.42
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 7.42
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 7.39
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 7.34
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.33
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 7.29
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 7.25
Transcriptome analysis in Neobractatin treated cells 7.22
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 7.21
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 7.21
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 7.2
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 7.15
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 7.14
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.12
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 7.12
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 7.11
Modeling Familial Cancer with iPSC Approaches 7.11
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 7.06
RNA-Seq from early time points in the kidney differentiation protocol 7.05
Gene expression profiling of human and murine in vitro muscle differentiation 7.04
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 7.03
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 7.03
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 7.02
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 7.02
Global analyses of the effect of different cellular contexts on microRNA targeting 7.02
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 7.02
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 7.01
The bromodomain protein BRD4 regulates splicing during heat shock 6.99
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.96
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 6.96
The pause-initiation limit restricts transcription activation in human cells 6.93
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 6.92
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 6.89
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 6.88
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 6.88
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.81
Differential gene expression of human melanoma cells [RNA-seq] 6.81
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 6.77
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 6.71
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.68
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.67
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 6.67
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 6.66
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 6.66
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 6.66
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.66
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.65
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.65
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 6.61
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 6.61
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.57
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 6.56
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 6.52
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.52
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 6.51
RNA-seq of YB5 cells treated with Proscillaridin A 6.49
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 6.45
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.42
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.42
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.42
ADAR1-editing of cellular and measles virus-derived duplex RNA 6.39
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 6.39
Fibroblasts in cholesteatoma activate osteoclasts. 6.38
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 6.37
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 6.36
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 6.36
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.34
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 6.33
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 6.29
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 6.25
Metastasis in triple-negative breast cancer 6.25
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.24
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 6.17
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 6.17
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.15
TT-Seq captures the human transient transcriptome 6.14
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 6.1
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.1
The Genomic Landscape of Atypical Fibroxanthoma 6.1
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 6.09
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.08
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.03
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 6.01
Morphological and molecular characterization of human dermal lymphatic collectors 5.97
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.97
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.96
Exploring the RNA landscape of endothelial exosomes 5.91
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 5.87
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 5.87
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 5.8
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.75
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.7
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 5.68
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.68
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 5.63
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 5.59
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 5.58
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 5.56
High-throughput sequencing of PROMPT-enriched samples. 5.55
The human blood-nerve barrier transcriptome 5.53
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.51
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.45
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.45
Determining mRNA half-lives on a transcriptome-wide scale 5.44
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.44
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 5.42
Regulation of poly(A) tail and translation during the somatic cell cycle 5.41
CD73 knockdown effect in pancreatic cancer cell lines 5.39
Studying the selectivity of a small molecule Synucleozid on transcriptome 5.29
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 5.25
Global expression profiles in cardiac progenitor cells generated by ISX-9 5.25
An optimization system for isolating and sequencing of single human colon cancer cells 5.19
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.15
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.15
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 5.09
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 5.02
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.99
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.93
RNA editing in nascent RNA affects pre-mRNA splicing 4.83
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.77
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 4.76
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 4.76
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.71
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.71
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 4.63
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.62
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 4.61
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.56
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.56
O-glcnAc reprograms cellular energetics 4.53
scRNASeq analysis of cycling cardiomyocytes 4.52
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 4.48
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.47
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.46
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 4.43
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 4.4
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 4.4
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.36
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 4.36
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 4.3
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 4.21
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.2
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.17
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 4.14
Regulatory network controlling tumor-promoting inflammation in human cancers 4.09
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 4.09
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 4.08
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 4.07
METTL3 and WTAP 4.07
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.98
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.96
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 3.95
Trascriptome of thyroid cancer-induced macrophages 3.94
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.94
The Glioma-Infiltrating T Cell Receptor Repertoire 3.91
A single-cell transcriptome atlas of the human pancreas 3.88
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.85
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 3.8
The role of m6A/m-RNA methylation in stress response regulation 3.8
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 3.73
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 3.73
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 3.72
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 3.7
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.7
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.7
RNA-seq analysis of the human fetal kidney. 3.69
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.69
In vitro modeling of human germ cell development using pluripotent stem cells 3.67
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 3.64
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.59
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.59
HBEC-shp53-PCHD7 3.57
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 3.45
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.44
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.43
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.43
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.42
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.39
Hepatitis C virus functionally sequesters miR-122 3.39
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.31
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.28
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.28
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 3.24
mRNA expression in human DAOY cells 3.21
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.21
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 3.08
Tracking distinct RNA populations using efficient and reversible covalent chemistry 3.04
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.03
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 3.01
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 3.01
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.0
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.0
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.98
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.97
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.97
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.97
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.9
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 2.89
miR-93 Targets in Human Endothelial Cells 2.86
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.85
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.84
Functional significance of the HIV-1 Tat signature amino acid residues 2.74
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.7
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.7
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.59
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.59
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.58
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 2.58
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.55
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.53
Induced DNA demethylation, genome instability and transcription 2.51
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.51
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.5
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 2.49
Targeting MTHFD2 in Acute Myeloid Leukemia 2.45
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 2.43
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.42
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.39
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.37
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.35
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.35
Iron response of HepG2 cells 2.35
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.33
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.3
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 2.29
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.25
Enhancer activation during EGF response 2.21
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.12
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.12
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 2.12
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.11
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.1
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.07
Hepatocyte maturation 2.05
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.03
RNA Sequencing of Human iPS derived Cardiomyocytes 2.0
RNA-seq of IL-4 stimulated human keratinocytes 1.99
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.95
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.92
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.92
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.92
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.92
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.92
Gene expression analysis of human adenomas. 1.79
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.69
Transposon-based construction of strand-specific RNA-seq libraries 1.67
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.66
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.65
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.65
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.64
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.63
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.6
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.6
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.53
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 1.47
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 1.47
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.44
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.4
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.39
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.36
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 1.34
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.26
RNA-sequencing of human tendon after injury 1.25
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.23
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.23
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.21
Interphase condensins regulate ligand-depedent enhancer activation 1.2
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.2
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.16
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.15
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 1.12
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.11
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.11
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.11
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.1
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.05
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.04
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.95
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.92
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.92
Profiling of escape kinetics of viruses subjected to RNAi 0.92
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.91
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.89
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.87
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.83
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.82
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.77
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.76
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.76
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.75
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.69
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.65
6mer seed toxicity in viral microRNAs 0.64
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 0.62
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 0.62
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.61
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.57
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.57
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.57
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.51
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.47
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.46
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.46
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.39
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.37
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.37
MHC Transcriptomic landscape at haplotype-specific resolution 0.35
RNA-seq data 0.34
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.33
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.31
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.29
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.28
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.24
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.22
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.17
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.14
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.14
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.12
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.12
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.1
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.08
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.07
Positively selected enhancer elements endow tumor cells with metastatic competence 0.05
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.04
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.03
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.03
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.02
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation